Emergent BioSolutions Expands Ready to Rescue Initiative to Support Widespread Opioid Emergency Preparedness
Emergent BioSolutions (NYSE: EBS) has launched the second year of its Ready to Rescue initiative, expanding efforts to increase awareness and availability of NARCAN® Nasal Spray for opioid emergency preparedness. The campaign, featuring pro football legend Emmitt Smith, will include new college football tailgate stops, in-stadium activities, Greek Life events, and student wellness clinics.
The initiative aims to educate communities on opioid risks and how to be prepared with NARCAN® Nasal Spray, which is now available over-the-counter. Targeting college communities, where opioid misuse and dependency rates are highest among 18-25 year-olds, the campaign will visit several universities this fall to provide education and Ready to Rescue kits.
Emergent emphasizes the importance of widespread access to NARCAN® Nasal Spray, as opioid poisonings remain the leading cause of accidental death in the United States, despite a recent reduction in drug overdose deaths.
Emergent BioSolutions (NYSE: EBS) ha lanciato il secondo anno della sua iniziativa Ready to Rescue, ampliando gli sforzi per aumentare la consapevolezza e la disponibilità di NARCAN® Nasal Spray per la preparazione alle emergenze legate agli oppiacei. La campagna, che vede come protagonista la leggenda del football professionistico Emmitt Smith, includerà nuove fermate nei tailgate del football universitario, attività negli stadi, eventi della vita greca e cliniche di benessere per studenti.
L'iniziativa punta a educare le comunità sui rischi degli oppiacei e su come essere preparati con il NARCAN® Nasal Spray, ora disponibile senza prescrizione. Rivolgendosi alle comunità universitarie, dove i tassi di abuso e dipendenza da oppiacei sono più elevati tra i giovani di età compresa tra 18 e 25 anni, la campagna visiterà diverse università questo autunno per fornire educazione e Ready to Rescue kits.
Emergent sottolinea l'importanza di un accesso diffuso al NARCAN® Nasal Spray, poiché le intossicazioni da oppiacei rimangono la principale causa di morte accidentale negli Stati Uniti, nonostante una recente diminuzione dei decessi per overdose di droga.
Emergent BioSolutions (NYSE: EBS) ha lanzado el segundo año de su iniciativa Ready to Rescue, ampliando los esfuerzos para aumentar la concienciación y la disponibilidad de NARCAN® Nasal Spray para la preparación ante emergencias relacionadas con opioides. La campaña, que presenta a la leyenda del fútbol profesional Emmitt Smith, incluirá nuevas paradas en los tailgates de fútbol universitario, actividades en el estadio, eventos de vida griega y clínicas de bienestar estudiantil.
La iniciativa tiene como objetivo educar a las comunidades sobre los riesgos de los opioides y cómo estar preparados con NARCAN® Nasal Spray, que ahora está disponible sin receta. Dirigida a las comunidades universitarias, donde las tasas de uso indebido y dependencia de opioides son más altas entre los jóvenes de 18 a 25 años, la campaña visitará varias universidades este otoño para proporcionar educación y Ready to Rescue kits.
Emergent enfatiza la importancia del acceso generalizado al NARCAN® Nasal Spray, ya que las intoxicaciones por opioides siguen siendo la principal causa de muerte accidental en los Estados Unidos, a pesar de una reciente reducción en las muertes por sobredosis de drogas.
Emergent BioSolutions (NYSE: EBS)는 Ready to Rescue 이니셔티브의 두 번째 해를 시작하며 오피오이드 응급 준비를 위한 NARCAN® Nasal Spray의 인식 제고 및 가용성 확대를 위한 노력을 더욱 강화하고 있습니다. 이번 캠페인은 축구 전설 Emmitt Smith가 참여하며, 대학 미식축구의 테일게이트 행사, 경기장 내 활동, 그리스 문화 행사 및 학생 웰니스 클리닉이 포함됩니다.
이 이니셔티브는 커뮤니티에 오피오이드 위험성을 교육하고 NARCAN® Nasal Spray를 사용하여 어떻게 준비할 수 있는지를 알려주는 것을 목표로 하며, 이는 이제 처방전 없이 구입할 수 있습니다. 주로 18-25세 사이의 오피오이드 남용 및 의존율이 가장 높은 대학 커뮤니티를 대상으로, 이번 가을 여러 대학을 방문하여 교육과 함께 Ready to Rescue kits를 제공할 예정입니다.
Emergent는 NARCAN® Nasal Spray에 대한 광범위한 접근이 중요하다는 점을 강조하며, 오피오이드 중독이 미국에서 사고사 주요 원인으로 남아있음을 언급하고 있습니다. 최근 약물 과다복용 사망률이 감소했음에도 불구하고 여전히 심각한 상황입니다.
Emergent BioSolutions (NYSE: EBS) a lancé la deuxième année de son initiative Ready to Rescue, élargissant ses efforts pour accroître la sensibilisation et la disponibilité du NARCAN® Nasal Spray en matière de préparation aux urgences liées aux opioïdes. La campagne, mettant en vedette la légende du football professionnel Emmitt Smith, comprendra de nouveaux arrêts de tailgate au football universitaire, des activités dans les stades, des événements de la vie grecque et des cliniques de bien-être étudiant.
L'initiative vise à éduquer les communautés sur les risques liés aux opioïdes et comment se préparer avec le NARCAN® Nasal Spray, qui est maintenant disponible sans ordonnance. Ciblant les communautés universitaires, où les taux d'abus et de dépendance aux opioïdes sont les plus élevés chez les 18-25 ans, la campagne visitera plusieurs universités cet automne pour fournir éducation et Ready to Rescue kits.
Emergent souligne l'importance d'un accès généralisé au NARCAN® Nasal Spray, car les intoxications aux opioïdes restent la première cause de décès accidentels aux États-Unis, malgré une récente réduction des décès par surdose de drogues.
Emergent BioSolutions (NYSE: EBS) hat das zweite Jahr seiner Ready to Rescue-Initiative gestartet und erweitert seine Bemühungen zur Sensibilisierung und Verfügbarkeit des NARCAN® Nasal Spray für die Notfallvorbereitung bei Opioiden. Die Kampagne, die die Fußballlegende Emmitt Smith hervorhebt, umfasst neue Tailgate-Stopps bei College-Football-Veranstaltungen, Aktivitäten im Stadion, Veranstaltungen der griechischen Gemeinschaft und Wellnesskliniken für Studenten.
Die Initiative zielt darauf ab, die Gemeinschaften über die Risiken von Opioiden zu informieren und wie man sich mit dem NARCAN® Nasal Spray, das jetzt rezeptfrei erhältlich ist, vorbereiten kann. Die Kampagne richtet sich an College-Communities, in denen die Missbrauchs- und Abhängigkeitsraten von Opioiden unter den 18- bis 25-Jährigen am höchsten sind, und wird in diesem Herbst mehrere Universitäten besuchen, um Bildung und Ready to Rescue kits bereitzustellen.
Emergent betont die Bedeutung des weitreichenden Zugangs zum NARCAN® Nasal Spray, da Opioidvergiftungen nach wie vor die häufigste Ursache für versehentliche Todesfälle in den Vereinigten Staaten sind, trotz eines kürzlichen Rückgangs der Drogenüberdosis-Todesfälle.
- Expansion of Ready to Rescue initiative to increase awareness and availability of NARCAN® Nasal Spray
- NARCAN® Nasal Spray now available over-the-counter, potentially increasing accessibility
- Partnership with high-profile spokesperson Emmitt Smith to raise awareness
- Opioid poisonings continue to be the leading cause of accidental death in the United States
- Less than 15% of college students nationwide know how to administer naloxone
- For the second year, Emergent is teaming up with pro football legend, Emmitt Smith, to educate communities on opioid risks and how to be prepared with NARCAN® Nasal Spray
- In recognition of International Overdose Awareness Day, Emergent is bolstering efforts to increase awareness and availability of naloxone to ensure everyone has the power to save a life
GAITHERSBURG, Md., Aug. 30, 2024 (GLOBE NEWSWIRE) -- Today, Emergent BioSolutions Inc. (NYSE: EBS) announced it is kicking off the second year of the Ready to Rescue initiative, which will include new college football tailgate stops, in-stadium activities, Greek Life events and student wellness clinics. As part of these expanded efforts, pro football legend and campaign spokesperson, Emmitt Smith, will continue to share his story to raise awareness of opioid risks and inspire students, parents, faculty and alumni to be prepared to save a life with NARCAN® Nasal Spray, which is available over-the-counter (OTC).
The Centers for Disease Control and Prevention (CDC) recently announced a reduction in drug overdose deaths for the first time since 2018.1 However, opioid poisonings continue to be the leading cause of accidental death in the United States,2 with the highest rate of opioid misuse and dependency among those 18 to 25.3 What’s more, research shows less than 15 percent of college students nationwide know how to administer naloxone,4 the active ingredient in NARCAN® Nasal Spray, which can reverse the effects of an opioid overdose, including those caused by fentanyl. Education on the dangers of fentanyl, the signs of an opioid poisoning and how to both access and administer NARCAN® Nasal Spray is vital to saving lives, particularly within college communities.
“Too many young adults have tragically lost their lives to accidental opioid poisonings caused by fentanyl,” said Paul Williams, senior vice president, products business. “And we know from our research that approximately
This fall, Ready to Rescue will be on the ground at Clemson University, University of Florida, Arizona State University and the University of Wisconsin-Madison. Activities at college football tailgates, Greek Life and student wellness clinics are aimed at breaking down the stigma around accidental opioid poisonings, which can happen anytime, anywhere and to anyone.6 Attendees will experience live NARCAN® Nasal Spray demonstrations and receive Ready to Rescue kits with information on the signs of an opioid emergency and how to help save a life with naloxone using the simple Lay, Spray, Stay method.
“Being part of the Ready to Rescue program, has been a moving and eye-opening experience that hits close to home for me,” said Smith. “Going into communities, I am saddened to hear so many tragic stories, including my family, friends and teammates who have lost loved ones to an opioid overdose, but I am also encouraged by everyone who is willing to step up and be ready to help save a life. As a father of five, I hope I can continue to foster open dialogue about opioid risks and share life-saving resources, so we can make a safer world for our children and future generations.”
August 31st is International Overdose Awareness Day and the Ready to Rescue initiative embodies this year's theme of “Together We Can” as Emergent and Smith rally Americans from all walks of life to come together to save lives. Stemming the tide of the opioid epidemic requires a consistent multi-channel and multi-partner effort, which is why Emergent remains laser focused on working with advocacy partners, government leaders, public interest groups, payers and retailers with the goal of broadening awareness and availability of NARCAN® Nasal Spray. It’s critical that every school, venue, business and individual nationwide has access to this medication because you never know when you might be in the right place, at the right time to help save a life.
Visit ReadytoRescue.com to learn more about the initiative and how you can be prepared to save a life with NARCAN® Nasal Spray.
Emmitt Smith is a paid spokesperson for Emergent.
About NARCAN® Nasal Spray
NARCAN® Naloxone HCl Nasal Spray 4 mg is the first FDA-approved, over-the-counter (OTC) 4 mg naloxone product for the emergency treatment of opioid overdose. NARCAN® Nasal Spray is not a substitute for emergency medical care. Repeat dosing may be necessary. Use as directed.
About Emergent BioSolutions
At Emergent, our mission is to protect and enhance life. For 25 years, we’ve been at work defending people from things we hope will never happen—so we are prepared just in case they ever do. We provide solutions for complex and urgent public health threats through a portfolio of vaccines and therapeutics that we develop and manufacture for governments and consumers. We also offer a range of integrated contract development and manufacturing services for pharmaceutical and biotechnology customers. To learn more about how we plan to protect or enhance 1 billion lives by 2030, visit our website and follow us on LinkedIn, X, Instagram, Apple Podcasts and Spotify.
Investor Contact:
Richard S. Lindahl
Executive Vice President, CFO
lindahlr@ebsi.com
Media Contact:
Assal Hellmer
Vice President, Communications
mediarelations@ebsi.com
1 Centers for Disease Control and Prevention. Provisional Drug Overdose Death Counts. Updated February 15, 2023. Accessed July 22, 2024. https://www.cdc.gov/nchs/nvss/vsrr/drug-overdose-data.htm
2 Schiller EY, Goyal A, Mechanic OJ. Opioid Overdose. [Updated 2023 Jul 21]. Available from: https://www.ncbi.nlm.nih.gov/books/NBK470415/
3 Rath, J.M., Perks, S.N., Vallone, D.M., Barton, A.A., Stephens, D.K., Simard, B., Hair, E.C. Educating Young Adults about Opioid Misuse: Evidence from a Mass Media Intervention. Int. J. Environ. Res. Public Health 2022, 19, 22. https://doi.org/10.3390/ijerph19010022
4 Freibott CE, Vest N, Stein MD, Lipson SK. Opioid Overdose Knowledge Among Adolescents and Young Adults. JAMA Pediatr. 2024;178(6):618–620. doi:10.1001/jamapediatrics.2024.0561.
5 Bryter Inc. interviewed 1,005 American adults online between April 24 through April 28, 2024. The survey was designed to be representative of the American adult population a whole by age, gender, region and HHI (+/-
6 Centers for Disease Control and Prevention. Preventing an Opioid Overdose Know the Signs Save a Life. https://www.cdc.gov/drugoverdose/pdf/patients/Preventing-an-Opioid-Overdose-Tip-Card-a.pdf.
FAQ
What is the Ready to Rescue initiative by Emergent BioSolutions (EBS)?
Which universities will the Ready to Rescue initiative visit in 2024?
What is the significance of NARCAN® Nasal Spray being available over-the-counter for Emergent BioSolutions (EBS)?
How is Emergent BioSolutions (EBS) addressing the opioid crisis among college students?
